Category: Healthcare and Pharmaceutical
Publish Date: November 2023
No. of Pages: 250
Format: Pdf
Licensing options
Executive Summary
Azoth Analytics has released a research report titled “Global Thyroid Eye Disease Treatment Market (2023 Edition)†which provides a complete analysis of the global Thyroid Eye Disease Treatment industry in terms of market segmentation by Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, Other Therapeutics), Route of Administration (Oral, Parenteral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel), By Region and By Country. The market has been assessed for the historical period of 2018-2022, the estimates of 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research also analyzes growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
During the forecast period, 2024-2029, the Global Thyroid Eye Disease Treatment market is expected to grow at a CAGR of 13.24%. The Global Thyroid Eye Disease Treatment Market is expected to generate USD 8.24 Billion by the end of 2029, up from USD 3.46 Billion in 2022.
The market for treatments of thyroid eye disease (TED) is witnessing substantial expansion as a result of the increasing prevalence of this ailment. Graves' disease, a prevalent autoimmune illness that affects the thyroid gland, is frequently linked to TED (thyroid eye disease). The prevalence of autoimmune disorders, such as Graves' disease, is on the rise, leading to a corresponding increase in the number of cases of thyroid eye disease (TED). The expansion of the patient population contributes to the increasing demand for TED treatments.
The introduction of biologic pharmaceuticals and targeted therapies is altering the landscape of TED treatment. In clinical trials, monoclonal antibodies that target specific immune response molecules, such as the IL-6 receptor and IGF-1 receptor, have demonstrated potential. These biologics can assist in modulating the immune response, reducing inflammation, and relieving TED symptoms. The development of these specialized treatments offers patients with mild to severe TED new treatment options.
Scope of the Report
• The report analyses the Thyroid Eye Disease Treatment Market by Value (USD Million).
• The report presents the analysis of Thyroid Eye Disease Treatment Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Thyroid Eye Disease Treatment Market by Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins).
• The report analyses the Thyroid Eye Disease Treatment Market By Route of Administration (Oral, Parenteral, Topical)
• The report analyses the Thyroid Eye Disease Treatment Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channels).
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Therapeutic Type, By Route of Administration and by Distribution Channels.
• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Horizon Therapeutics, GSK plc, Santen Pharmaceuticals, Viridian Therapeutics, Bioxcel Therapeutics, Novartis AG, Roche Holding AG, Sanofi, Teva Pharmaceuticals, Abbvie Inc.
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
3. Global Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
3.1 Clinical Signs Of Thyroid Eye Disease
3.2 Signs and symptoms due to excess thyroid hormones
3.3 Global Thyroid Eye Disease Treatment Market: Dashboard
3.4 Global Thyroid Eye Disease Treatment Market: Market Value Assessment, 2018-2028 (USD Million)
3.5 Impact of COVID-19 on Global Thyroid Eye Disease Treatment Market
3.6 Global Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
3.6.1 Global Thyroid Eye Disease Treatment Market, By Therapeutic Type Type Overview
3.6.2 Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
3.6.3 Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
3.6.4 Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
3.6.5 Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
3.7 Global Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
3.7.1 Global Thyroid Eye Disease Treatment Market, By Route of Administration Overview
3.7.2 Global Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
3.7.3 Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
3.7.4 Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
3.8 Global Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
3.8.1 Global Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
3.8.2 Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies By Value, 2018H-2028F (USD Million & CAGR)
3.8.3 Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
3.8.4 Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
4. Global Thyroid Eye Disease Treatment Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
5.1 Americas Thyroid Eye Disease Treatment Market: Snapshot
5.2 Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.3 Americas Thyroid Eye Disease Treatment Market: Key Factors
5.4 Americas Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
5.4.1 Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
5.4.2 Americas Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
5.4.3 Americas Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
5.4.4 Americas Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
5.4.5 Americas Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
5.5 Americas Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
5.5.1 Americas Thyroid Eye Disease Treatment Market, By Route of Administration Overview
5.5.2 Americas Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
5.5.3 Americas Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
5.5.4 Americas Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
5.6 Americas Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
5.6.1 Americas Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
5.6.2 Americas Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.6.3 Americas Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
5.6.4 Americas Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
5.7 Americas Thyroid Eye Disease Treatment Market Segmentation: By Country
5.7.1 United States Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.1.1 United States Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.7.1.2 United States Thyroid Eye Disease Treatment Market, By Route of Administration
5.7.1.3 United States Thyroid Eye Disease Treatment Market, By Distribution Channel
5.7.2 Canada Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.2.1 Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.7.2.2 Canada Thyroid Eye Disease Treatment Market, By Route of Administration
5.7.2.3 Canada Thyroid Eye Disease Treatment Market, By Distribution Channel
5.7.3 Rest of Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
5.7.3.1 Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type
5.7.3.2 Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration
5.7.3.3 Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration
6. Europe Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
6.1 Europe Thyroid Eye Disease Treatment Market: Snapshot
6.2 Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.3 Europe Thyroid Eye Disease Treatment Market: Key Factors
6.4 Europe Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
6.4.1 Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
6.4.2 Europe Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
6.4.3 Europe Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
6.4.4 Europe Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
6.4.5 Europe Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
6.5 Europe Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
6.5.1 Europe Thyroid Eye Disease Treatment Market, By Route of Administration Overview
6.5.2 Europe Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
6.5.3 Europe Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
6.5.4 Europe Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
6.6 Europe Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
6.6.1 Europe Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
6.6.2 Europe Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.6.3 Europe Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
6.6.4 Europe Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
6.7 Europe Thyroid Eye Disease Treatment Market Segmentation: By Country
6.7.1 Germany Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.1.1 Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.1.2 Germany Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.1.3 Germany Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.2 United Kingdom Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.2.1 United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.2.2 United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.2.3 United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.3 France Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.3.1 France Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.3.2 France Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.3.3 France Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.4 Italy Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.4.1 Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.4.2 Italy Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.4.3 Italy Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.5 Spain Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.5.1 Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.5.2 Spain Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.5.3 Spain Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.6 Rest of Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.6.1 Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.6.2 Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.6.3 Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel
6.7.6 Rest of Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
6.7.6.1 Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type
6.7.6.2 Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration
6.7.6.3 Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel
7. Asia-Pacific Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
7.1 Asia-Pacific Thyroid Eye Disease Treatment Market: Snapshot
7.2 Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.3 Asia-Pacific Thyroid Eye Disease Treatment Market: Key Factors
7.4 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
7.4.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
7.4.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
7.4.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
7.4.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
7.4.5 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
7.5 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
7.5.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration Overview
7.5.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
7.5.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
7.5.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
7.6 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
7.6.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel Overview
7.6.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.6.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
7.6.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
7.7 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Country
7.7.1 China Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.1.1 China Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.7.1.2 China Thyroid Eye Disease Treatment Market, By Route of Administration
7.7.1.3 China Thyroid Eye Disease Treatment Market, By Distribution Channel
7.7.2 Japan Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.1.1 Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.7.1.2 Japan Thyroid Eye Disease Treatment Market, By Route of Administration
7.7.1.3 Japan Thyroid Eye Disease Treatment Market, By Distribution Channel
7.7.3 India Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.3.1 India Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.7.3.2 India Thyroid Eye Disease Treatment Market, By Route of Administration
7.7.3.3 India Thyroid Eye Disease Treatment Market, By Distribution Channel
7.7.5 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
7.7.5.1 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type
7.7.5.2 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration
7.7.5.3 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel
8. Middle-East & Africa Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)
8.1 Middle-East & Africa Thyroid Eye Disease Treatment Market: Snapshot
8.2 Middle-East & Africa Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)
8.3 Middle-East & Africa Thyroid Eye Disease Treatment Market: Key Factors
8.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type
8.4.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview
8.4.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)
8.4.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)
8.4.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)
8.4.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)
8.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration
8.5.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Route of Administration Overview
8.5.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)
8.5.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)
8.5.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)
8.6 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel
8.6.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Distribution Channel: Overview
8.6.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.6.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)
8.6.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on the Global Thyroid Eye Disease Treatment Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Porter’s Five Forces Analysis
10.1 Porter’s Five Forces Model
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Thyroid Eye Disease Treatment Market
11.4 Company Profiles
11.4.1 Horizon Therapeutics
11.4.2 GSK plc
11.4.3 Santen Pharmaceuticals
11.4.4 Viridian Therapeutics
11.4.5 Bioxcel Therapeutics
11.4.6 Novartis AG
11.4.7 Roche Holding AG
11.4.8 Sanofi
11.4.9 Teva Pharmaceuticals
11.4.10 Abbvie Inc
List of Figures
Figure 1: Global Thyroid Eye Disease Treatment Market Size, By Value, 2019-2022 (USD Million)
Figure 2: Global Thyroid Eye Disease Treatment Market Size, By Value, 2023-2029 (USD Million)
Figure 3: Global Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 4: Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 5: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Monoclonal Antibodies, 2019-2029 (USD Million)
Figure 6: Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 7: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Corticosteroids, 2019-2029 (USD Million)
Figure 8: Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 9: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Vitamins, 2019-2029 (USD Million)
Figure 10: Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 11: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Other Therapeutics, 2019-2029 (USD Million)
Figure 12: Global Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 13: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Oral, 2019-2029 (USD Million)
Figure 14: Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 15: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Parenteral, 2019-2029 (USD Million)
Figure 16: Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2019H-2029F (USD Million & CAGR)`
Figure 17: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Topical, 2019-2029 (USD Million)
Figure 18: Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 19: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Hospital Pharmacies, 2019-2029 (USD Million)
Figure 20: Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 21: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Retail Pharmacies, 2019-2029 (USD Million)
Figure 22: Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 23: Global Thyroid Eye Disease Treatment Market Absolute Opportunity, By Online Channel, 2019-2029 (USD Million)
Figure 24: Americas Thyroid Eye Disease Treatment Market Size, By Value, 2019H-2029F (USD Million)
Figure 25: Americas Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 26: Americas Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 27: Americas Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 28: Americas Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 29: Americas Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 30: Americas Thyroid Eye Disease Treatment Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 31: Americas Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 32: Americas Thyroid Eye Disease Treatment Market, By Topical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 33: Americas Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 34: Americas Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 35: Americas Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 36: United States Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 37: United States Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 38: United States Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 39: United States Thyroid Eye Disease Treatment Market Share, By Route of Administration, By Value, 2022 (%)
Figure 40: United States Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 41: Canada Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 42: Canada Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 43: Canada Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 44: Canada Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 45: Canada Thyroid Eye Disease Treatment Market Share, Distribution Channel, 2022 (%)
Figure 46: Rest of Americas Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 47: Rest of Americas Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 48: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 49: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 50: Rest of Americas Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 51: Europe Thyroid Eye Disease Treatment Market Size, By Value, 2019H-2029F (USD Million)
Figure 52: Europe Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 53: Europe Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 54: Europe Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 55: Europe Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 56: Europe Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 57: Europe Thyroid Eye Disease Treatment Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 58: Europe Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 59: Europe Thyroid Eye Disease Treatment Market, By Topical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 60: Europe Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 61: Europe Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 62: Europe Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 63: Germany Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 64: Germany Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 65: Germany Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 66: Germany Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 67: Germany Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 68: United Kingdom Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 69: United Kingdom Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 70: United Kingdom Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 71: United Kingdom Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 72: United Kingdom Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 73: France Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 74: France Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 75: France Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 76: France Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 77: France Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 78: Italy Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 79: Italy Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 80: Italy Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 81: Italy Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 82: Italy Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 83: Spain Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 84: Spain Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 85: Spain Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 86: Spain Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 87: Spain Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 88: Rest of Europe Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 89: Rest of Europe Thyroid Eye Disease Treatment Market Value, By Therapeutic Type, 2022 (USD Million)
Figure 90: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 91: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 92: Rest of Europe Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 93: Asia Pacific Thyroid Eye Disease Treatment Market Size, By Value, 2019H-2029F (USD Million)
Figure 94: Asia Pacific Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 95: Asia Pacific Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 96: Asia Pacific Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 97: Asia Pacific Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 98: Asia Pacific Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 99: Asia Pacific Thyroid Eye Disease Treatment Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 100: Asia Pacific Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 101: Asia Pacific Thyroid Eye Disease Treatment Market, By Topical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 102: Asia Pacific Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 103: Asia Pacific Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 104: Asia Pacific Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 105: China Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 106: China Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2022 (USD Million)
Figure 107: China Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 108: China Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 109: China Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 110: Japan Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 111: Japan Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2022 (USD Million)
Figure 112: Japan Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 113: Japan Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 114: Japan Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 115: India Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 116: India Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2022 (USD Million)
Figure 117: India Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 118: India Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 119: India Thyroid Eye Disease Treatment Market Share, Distribution Channel, 2022 (%)
Figure 120: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 121: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Value, By Route of Administration, 2022 (USD Million)
Figure 122: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, By Value, 2022 (%)
Figure 123: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Route of Administration, 2022 (%)
Figure 124: Rest of Asia Pacific Thyroid Eye Disease Treatment Market Share, By Distribution Channel, 2022 (%)
Figure 125: Middle East and Africa Thyroid Eye Disease Treatment Market Size, By Value, 2019H-2029F (USD Million)
Figure 126: Middle East and Africa Thyroid Eye Disease Treatment Market Share, By Therapeutic Type, 2022 (%)
Figure 127: Middle East and Africa Thyroid Eye Disease Treatment Market, By Monoclonal Antibodies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 128: Middle East and Africa Thyroid Eye Disease Treatment Market, By Corticosteroids, By Value, 2019H-2029F (USD Million & CAGR)
Figure 129: Middle East and Africa Thyroid Eye Disease Treatment Market, By Vitamins, By Value, 2019H-2029F (USD Million & CAGR)
Figure 130: Middle East and Africa Thyroid Eye Disease Treatment Market, By Other Therapeutics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 131: Middle East and Africa Thyroid Eye Disease Treatment Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 132: Middle East and Africa Thyroid Eye Disease Treatment Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
Figure 133: Middle East and Africa Thyroid Eye Disease Treatment Market, By Topical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 134: Middle East and Africa Thyroid Eye Disease Treatment Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 135: Middle East and Africa Thyroid Eye Disease Treatment Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 136: Middle East and Africa Thyroid Eye Disease Treatment Market, By Online Channel, By Value, 2019H-2029F (USD Million & CAGR)
Figure 137: Market Share of Prominent Companies of Thyroid Eye Disease Treatment Market, 2022 (%)
Figure 138: GSK PLC Revenue, 2020-2022 (USD Million)
Figure 139: GSK PLC Revenue, By Business Segments, 2022 (%)
Figure 140: GSK PLC Revenue, By Geography Segment, 2022 (%)
Figure 141: Santen Revenue, 2020-2022 (USD Million)
Figure 142: Santen Revenue, By Geography Segment, 2022 (%)
Figure 143: Santen Revenue, By Geography Segment, 2022 (%)
Figure 144: Novartis Revenue, 2020-2022 (USD Million)
Figure 145: Novartis Revenue, By Business Segments, 2022 (%)
Figure 146: Novartis Revenue, By Geographical Segments, 2022 (%)
Figure 147: Roche Revenue, 2020-2022 (USD Million)
Figure 148: Roche Revenue, By Business Segments, 2022 (%)
Figure 149: Roche Revenue, By Business Segments, 2022 (%)
Figure 150: Sanofi Revenues, 2020-2022 (USD Million)
Figure 151: Sanofi Revenues, By Geographic Segments, 2022 (%)
Figure 152: Sanofi Revenue, By Business Segments, 2022 (%)
Figure 153: Teva Pharmaceuticals Revenues, 2020-2022 (USD Million)
Figure 154: Teva Pharmaceuticals Revenue, By Geographical Segments, 2022 (%)
Figure 155: AbbVie Inc. Revenues, 2020-2022 (USD Million)
Figure 156: AbbVie Inc. Revenue, Product Sales by Business Segment, 2022 (%)
Figure 157: AbbVie Inc. Revenue, By Geographical Segments, 2022 (%)
List of Tables
Table A1: Changes in Eyelid
Table A2: Changes in Facial Muscles
Table A3: Changes in Extraocular Movement
Table A4: Changes in Pupil
Table A5: Other Signs
Table A6: Clinical manifestation of thyrotoxicosis
Table A7: United States Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A8: United States Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A9: United States Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A10: United States Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A11: United States Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A12: United States Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A13: Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A14: Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A15: Canada Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A16: Canada Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A17: Canada Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A18: Canada Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A19: Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A20: Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A21: Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A22: Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A23: Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A24: Rest of Americas Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A25: Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A26: Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A27: Germany Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A28: Germany Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A29: Germany Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A30: Germany Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A31: United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A32: United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A33: United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A34: United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A35: United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A36: United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A37: France Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A38: France Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A39: France Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A40: France Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A41: France Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A42: France Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A43: Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A44: Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A45: Italy Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A46: Italy Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A47: Italy Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A48: Italy Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A49: Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A50: Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A51: Spain Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A52: Spain Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A53: Spain Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A54: Spain Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A55: Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A56: Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A57: Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A58: Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A59: Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A60: Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A61: China Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A62: China Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A63: China Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A64: China Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A65: China Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A66: China Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A67: Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A68: Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A69: Japan Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A70: Japan Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A71: Japan Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A72: Japan Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A73: India Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A74: India Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A75: India Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A76: India Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A77: India Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A78: India Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A79: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2019-2022 (USD Million)
Table A80: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type, By Value, 2023-2029 (USD Million)
Table A81: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2019-2022 (USD Million)
Table A82: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Route of Administration, By Value, 2023-2029 (USD Million)
Table A83: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2019-2022 (USD Million)
Table A84: Rest of Asia Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel, By Value, 2023-2029 (USD Million)
Table A85: GSK PLC Key Company Financials, 2020-2022
Table A86: Santen Key Company Financials, 2020-2022
Table A87: Novartis Key Company Financials, 2020-2022
Table A88: Roche Key Company Financials, 2020-2022
Table A89: Sanofi Key Financials, 2020-2022
Table A90: Teva Pharmaceuticals Key Financials, 2020-2022
Table A91: AbbVie Inc. Key Company Financials, 2020-2022
Table A86: Santen Key Company Financials, 2020-2022
Table A87: Novartis Key Company Financials, 2020-2022
Table A88: Roche Key Company Financials, 2020-2022
Table A89: Sanofi Key Financials, 2020-2022
Table A90: Teva Pharmaceuticals Key Financials, 2020-2022
Table A91: AbbVie Inc. Key Company Financials, 2020-2022
.jpg)
Global Medical Device Regulatory Affairs Market (2024 Edition): Analysis By Type ...
Read More.jpg)
Global Infectious Disease In vitro Diagnostics Market (2024 Edition): Analysis B ...
Read More
Global Medical Tourism Market (2024 Edition): Analysis By Service Provider (Publ ...
Read More.jpg)
Global Oxygen Cylinders and Concentrators Market (2024 Edition): Analysis By Pro ...
Read More.jpg)
Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Femal ...
Read More.jpg)
Global Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Co ...
Read More.jpg)
Global Immune Thrombocytopenia Drug Market (2024 Edition): Analysis By Treatment ...
Read More.jpg)
Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): An ...
Read MoreNo matter the hour, we’re here to help.
Contact us now!.jpg){kind=logo}
Azoth Analytics (ISO 9001:2015) is a business research and analytics company that creates in-depth research reports and provides customized research solutions and consulting services.
© 2024 Azoth Analytics | All rights reserved